However, for Q1 2025, Centene Corporation (NYSE:CNC) stated that premium and service revenues rose by 17% to $42.5 billion ...

Fintel reports that on July 16, 2025, B of A Securities downgraded their outlook for Centene (NYSE:CNC) from Neutral to ...

The Clayton-based health giant is likely to face increased challenges as federal government tightens Medicaid eligibility and ...

Shares of Centene are experiencing a historic collapse this week. Wednesday marked the worst single-day performance in the company's history.

Analysts have provided mixed ratings on Centene’s stock. Cantor Fitzgerald reiterated an Overweight rating with a $90 price target, citing limited impact from tightened Medicaid work requirements.

Investing.com -- Shares of Centene (NYSE:CNC) plunged more than 32% in premarket trading Wednesday after the company pulled its 2025 guidance, citing unexpectedly poor risk adjustment results in the ...

Investing.com -- Shares of Centene (NYSE:CNC) plunged more than 32% in premarket trading Wednesday after the company pulled its 2025 guidance, citing unexpectedly poor risk adjustment results in ...

Investing.com - JPMorgan downgraded Centene (NYSE:CNC), a $28.19 billion healthcare provider trading at 8.46x earnings, from Overweight to Neutral on Tuesday, slashing its price target to $48.00 ...

Meanwhile, Barclays downgraded Centene from Overweight to Equalweight, expressing concerns about the Part D and ACA segments and adjusting their earnings per share estimates downward for 2025 and ...